Optimizing triage and hospitalization in adult general medical emergency patients: the triage project

Philipp Schuetz, Pierre Hausfater, Devendra Amin, Sebastian Haubitz, Lukas Fässler, Eva Grolimund, Alexander Kutz, Ursula Schild, Zeljka Caldara, Katharina Regez, Andriy Zhydkov, Timo Kahles, Krassen Nedeltchev, Stefanie von Felten, Sabina De Geest, Antoinette Conca, Petra Schäfer-Keller, Andreas Huber, Mario Bargetzi, Ulrich Buergi, Gabrielle Sauvin, Pasqualina Perrig-Chiello, Barbara Reutlinger, Beat Mueller, Philipp Schuetz, Pierre Hausfater, Devendra Amin, Sebastian Haubitz, Lukas Fässler, Eva Grolimund, Alexander Kutz, Ursula Schild, Zeljka Caldara, Katharina Regez, Andriy Zhydkov, Timo Kahles, Krassen Nedeltchev, Stefanie von Felten, Sabina De Geest, Antoinette Conca, Petra Schäfer-Keller, Andreas Huber, Mario Bargetzi, Ulrich Buergi, Gabrielle Sauvin, Pasqualina Perrig-Chiello, Barbara Reutlinger, Beat Mueller

Abstract

Background: Patients presenting to the emergency department (ED) currently face inacceptable delays in initial treatment, and long, costly hospital stays due to suboptimal initial triage and site-of-care decisions. Accurate ED triage should focus not only on initial treatment priority, but also on prediction of medical risk and nursing needs to improve site-of-care decisions and to simplify early discharge management. Different triage scores have been proposed, such as the Manchester triage system (MTS). Yet, these scores focus only on treatment priority, have suboptimal performance and lack validation in the Swiss health care system. Because the MTS will be introduced into clinical routine at the Kantonsspital Aarau, we propose a large prospective cohort study to optimize initial patient triage. Specifically, the aim of this trial is to derive a three-part triage algorithm to better predict (a) treatment priority; (b) medical risk and thus need for in-hospital treatment; (c) post-acute care needs of patients at the most proximal time point of ED admission.

Methods/design: Prospective, observational, multicenter, multi-national cohort study. We will include all consecutive medical patients seeking ED care into this observational registry. There will be no exclusions except for non-adult and non-medical patients. Vital signs will be recorded and left over blood samples will be stored for later batch analysis of blood markers. Upon ED admission, the post-acute care discharge score (PACD) will be recorded. Attending ED physicians will adjudicate triage priority based on all available results at the time of ED discharge to the medical ward. Patients will be reassessed daily during the hospital course for medical stability and readiness for discharge from the nurses and if involved social workers perspective. To assess outcomes, data from electronic medical records will be used and all patients will be contacted 30 days after hospital admission to assess vital and functional status, re-hospitalization, satisfaction with care and quality of life measures. We aim to include between 5000 and 7000 patients over one year of recruitment to derive the three-part triage algorithm. The respective main endpoints were defined as (a) initial triage priority (high vs. low priority) adjudicated by the attending ED physician at ED discharge, (b) adverse 30 day outcome (death or intensive care unit admission) within 30 days following ED admission to assess patients risk and thus need for in-hospital treatment and (c) post acute care needs after hospital discharge, defined as transfer of patients to a post-acute care institution, for early recognition and planning of post-acute care needs. Other outcomes are time to first physician contact, time to initiation of adequate medical therapy, time to social worker involvement, length of hospital stay, reasons for discharge delays, patient's satisfaction with care, overall hospital costs and patients care needs after returning home.

Discussion: Using a reliable initial triage system for estimating initial treatment priority, need for in-hospital treatment and post-acute care needs is an innovative and persuasive approach for a more targeted and efficient management of medical patients in the ED. The proposed interdisciplinary , multi-national project has unprecedented potential to improve initial triage decisions and optimize resource allocation to the sickest patients from admission to discharge. The algorithms derived in this study will be compared in a later randomized controlled trial against a usual care control group in terms of resource use, length of hospital stay, overall costs and patient's outcomes in terms of mortality, re-hospitalization, quality of life and satisfaction with care.

Trial registration: ClinicalTrials.gov Identifier, NCT01768494.

Figures

Figure 1
Figure 1
Patient assessment for improved triaging of initial triage priority (Figure B), need for in hospital treatment (Figure C) and care needs (Figure D). Figure A shows the current conventional approach.
Figure 2
Figure 2
Guidelines for adjudication of initial treatment priority with practical examples. The main question for adjudicators will be “under difficult circumstances, what is the maximum possible time that this patient would have been able to wait before being seen?” adapted from on a previous study [37].

References

    1. Burt CW, McCaig LF, Rechtsteiner EA. Ambulatory medical care utilization estimates for 2005. Adv Data. 2007;388:1–15.
    1. McCaig LF, Burt CW. National Hospital Ambulatory Medical Care Survey emergency department summary. Adv Data. 2002;2004(340):1–34.
    1. Puskarich MA, Trzeciak S, Shapiro NI, Heffner AC, Kline JA, Jones AE. Emergency Medicine Shock Research N. Outcomes of patients undergoing early sepsis resuscitation for cryptic shock compared with overt shock. Resuscitation. 2011;82(10):1289–1293. doi: 10.1016/j.resuscitation.2011.06.015.
    1. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L. et al.Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589–1596. doi: 10.1097/01.CCM.0000217961.75225.E9.
    1. Adams HP Jr, Effron MB, Torner J, Davalos A, Frayne J, Teal P, Leclerc J, Oemar B, Padgett L, Barnathan ES. et al.Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II) Stroke; a journal of cerebral circulation. 2008;39(1):87–99. doi: 10.1161/STROKEAHA.106.476648.
    1. Cantor WJ, Fitchett D, Borgundvaag B, Ducas J, Heffernan M, Cohen EA, Morrison LJ, Langer A, Dzavik V, Mehta SR. et al.Routine early angioplasty after fibrinolysis for acute myocardial infarction. N Engl J Med. 2009;360(26):2705–2718. doi: 10.1056/NEJMoa0808276.
    1. Christ M, Grossmann F, Winter D, Bingisser R, Platz E. Modern triage in the emergency department. Deutsches Arzteblatt international. 2010;107(50):892–898.
    1. Grossmann FF, Nickel CH, Christ M, Schneider K, Spirig R, Bingisser R. Transporting clinical tools to new settings: cultural adaptation and validation of the Emergency Severity Index in German. Ann Emerg Med. 2011;57(3):257–264. doi: 10.1016/j.annemergmed.2010.07.021.
    1. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336(4):243–250. doi: 10.1056/NEJM199701233360402.
    1. Louis Simonet M, Kossovsky MP, Chopard P, Sigaud P, Perneger TV, Gaspoz JM. A predictive score to identify hospitalized patients’ risk of discharge to a post-acute care facility. BMC Health Serv Res. 2008;8:154. doi: 10.1186/1472-6963-8-154.
    1. Conca A, Bossart R, Regez K, Schild U, Wallimann G, Schweingruber R, Hantikainen V, Tobias P, Albrich WC, Ruegger K. et al.OPTIMA – Optimierter Patienten-Transfer durch innovatives multidisziplinäres Assessment - Projektbeschreibung der Phase I. PrInterNet - Zeitschrift für Pflegewissenschaft. 2012;14:291–298.
    1. Große-Schlarmann J. Der CMS© im ePA©. Verschiedene Qualitätsdimensionen eines Instruments. Eine empirische Analyse. Gelsenkirchen: Private Universität Witten/Herdecke gGmbH; 2007.
    1. Griffiths P, Wilson-Barnett J. The effectiveness of ‘nursing beds’: a review of the literature. J Adv Nurs. 1998;27(6):1184–1192. doi: 10.1046/j.1365-2648.1998.00655.x.
    1. Griffiths PD, Edwards MH, Forbes A, Harris RL, Ritchie G. Effectiveness of intermediate care in nursing-led in-patient units. Cochrane Database Syst Rev. 2007;2:CD002214.
    1. Griffiths P, Edwards M, Forbes A, Harris R. Post-acute intermediate care in nursing-led units: a systematic review of effectiveness. Int J Nurs Stud. 2005;42(1):107–116. doi: 10.1016/j.ijnurstu.2004.07.010.
    1. Harris R, Richardson G, Griffiths P, Hallett N, Wilson-Barnett J. Economic evaluation of a nursing-led inpatient unit: the impact of findings on management decisions of service utility and sustainability. J Nurs Manag. 2005;13(5):428–438. doi: 10.1111/j.1365-2834.2005.00589.x.
    1. Schuetz P, Christ-Crain M, Morgenthaler NG, Struck J, Bergmann A, Muller B. Circulating precursor levels of endothelin-1 and adrenomedullin, two endothelium-derived, counteracting substances, in sepsis. Endothelium : journal of endothelial cell research. 2007;14(6):345–351.
    1. Schuetz P, Wolbers M, Christ-Crain M, Thomann R, Falconnier C, Widmer I, Neidert S, Fricker T, Blum C, Schild U. et al.Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections. Crit Care. 2010;14(3):R106. doi: 10.1186/cc9055.
    1. Renaud B, Schuetz P, Claessens YE, Labarere J, Albrich W, Mueller B. Proadrenomedullin improves Risk of Early Admission to ICU score for predicting early severe community-acquired pneumonia. Chest. 2012;142(6):1447–1454. doi: 10.1378/chest.11-2574.
    1. Schuetz P, Christ-Crain M, Muller B. Procalcitonin and other biomarkers to improve assessment and antibiotic stewardship in infections–hope for hype? Swiss Med Wkly. 2009;139(23–24):318–326.
    1. Schuetz P, Christ-Crain M, Zimmerli W, Mueller B. Repeated measurements of endothelin-1 precursor peptides predict the outcome in community-acquired pneumonia. Intensive Care Med. 2011;37(6):970–980. doi: 10.1007/s00134-011-2208-2.
    1. Schuetz P, Jones AE, Aird WC, Shapiro NI. Endothelial cell activation in emergency department patients with sepsis-related and non-sepsis-related hypotension. Shock. 2011;36(2):104–108. doi: 10.1097/SHK.0b013e31821e4e04.
    1. Schuetz P, Muller B, Nusbaumer C, Wieland M, Christ-Crain M. Circulating levels of GH predict mortality and complement prognostic scores in critically ill medical patients. European journal of endocrinology / European Federation of Endocrine Societies. 2009;160(2):157–163.
    1. Vazquez M, Jockers K, Christ-Crain M, Zimmerli W, Muller B, Schuetz P. MR-pro-atrial natriuretic peptide (MR-proANP) predicts short- and long-term outcomes in respiratory tract infections: a prospective validation study. Int J Cardiol. 2012;156(1):16–23. doi: 10.1016/j.ijcard.2010.10.037.
    1. Schuetz P, Litke A, Albrich WC, Mueller B. Blood biomarkers for personalized treatment and patient management decisions in community-acquired pneumonia. Curr Opin Infect Dis. 2013;26(2):159–167.
    1. Schuetz P, Haubitz S, Mueller B. Do sepsis biomarkers in the emergency room allow transition from bundled sepsis care to personalized patient care? Curr Opin Crit Care. 2012;18(4):341–349. doi: 10.1097/MCC.0b013e328354b2c8.
    1. Christ-Crain M, Morgenthaler NG, Struck J, Harbarth S, Bergmann A, Muller B. Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study. Crit Care. 2005;9(6):R816–R824. doi: 10.1186/cc3885.
    1. Maisel A, Mueller C, Nowak R, Peacock WF, Landsberg JW, Ponikowski P, Mockel M, Hogan C, Wu AH, Richards M. et al.Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol. 2010;55(19):2062–2076. doi: 10.1016/j.jacc.2010.02.025.
    1. von-Haehling S, Filippatos GS, Papassotiriou J, Cicoira M, Jankowska EA, Doehner W, Rozentryt P, Vassanelli C, Struck J, Banasiak W. et al.Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure. Eur J Heart Fail. 2010;12(5):484–491. doi: 10.1093/eurjhf/hfq031.
    1. Melander O, Newton-Cheh C, Almgren P, Hedblad B, Berglund G, Engstrom G, Persson M, Smith JG, Magnusson M, Christensson A. et al.Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA. 2009;302(1):49–57. doi: 10.1001/jama.2009.943.
    1. Baehni C, Meier S, Spreiter P, Schild U, Regez K, Bossart R, Thomann R, Falconnier C, Christ-Crain M, De-Geest S. et al.Which patients with lower respiratory tract infections need inpatient treatment? Perceptions of physicians, nurses, patients and relatives. BMC Pulm Med. 2010;10:12. doi: 10.1186/1471-2466-10-12.
    1. Spreiter P, Meier S, Baehni C, Schild U, Regez K, Bossart R, Thomann R, Falconnier C, Christ-Crain M, Muller B. et al.Steps to Take to Reduce Length of Hospital Stay in Patients With Lower Respiratory Tract Infections: A Prospective Cohort Study. Home Health Care Management & Practice. 2010;10:1–8.
    1. Covinsky KE, Pierluissi E, Johnston CB. Hospitalization-associated disability: “She was probably able to ambulate, but I’m not sure”. JAMA. 2011;306(16):1782–1793. doi: 10.1001/jama.2011.1556.
    1. Albrich WC, Dusemund F, Ruegger K, Christ-Crain M, Zimmerli W, Bregenzer T, Irani S, Buergi U, Reutlinger B, Mueller B. et al.Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm. BMC Infect Dis. 2011;11:112. doi: 10.1186/1471-2334-11-112.
    1. Albrich WC, Ruegger K, Dusemund F, Bossart R, Regez K, Schild U, Conca A, Schuetz P, Sigrist T, Huber A. et al.Optimised patient transfer using an innovative multidisciplinary assessment in Kanton Aargau (OPTIMA I): an observational survey in lower respiratory tract infections. Swiss Med Wkly. 2011;141:w13237.
    1. Brooks R. EuroQol: the current state of play. Health Policy. 1996;37(1):53–72. doi: 10.1016/0168-8510(96)00822-6.
    1. Storm-Versloot MN, Ubbink DT, Kappelhof J, Luitse JS. Comparison of an informally structured triage system, the emergency severity index, and the manchester triage system to distinguish patient priority in the emergency department. Academic emergency medicine: official journal of the Society for Academic Emergency Medicine. 2011;18(8):822–829. doi: 10.1111/j.1553-2712.2011.01122.x.
    1. Stolz D, Christ-Crain M, Bingisser R, Leuppi J, Miedinger D, Muller C, Huber P, Muller B, Tamm M. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Chest. 2007;131(1):9–19. doi: 10.1378/chest.06-1500.
    1. Schuetz P, Christ-Crain M, Wolbers M, Schild U, Thomann R, Falconnier C, Widmer I, Neidert S, Blum CA, Schonenberger R. et al.Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial. BMC Health Serv Res. 2007;7:102. doi: 10.1186/1472-6963-7-102.
    1. Christ-Crain M, Stolz D, Bingisser R, Muller C, Miedinger D, Huber PR, Zimmerli W, Harbarth S, Tamm M, Muller B. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med. 2006;174(1):84–93. doi: 10.1164/rccm.200512-1922OC.
    1. Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, Muller B. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet. 2004;363(9409):600–607. doi: 10.1016/S0140-6736(04)15591-8.
    1. Briel M, Schuetz P, Mueller B, Young J, Schild U, Nusbaumer C, Periat P, Bucher HC, Christ-Crain M. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. Arch Intern Med. 2008;168(18):2000–2007. doi: 10.1001/archinte.168.18.2000. discussion 2007–2008.
    1. Schuetz P, Christ-Crain M, Thomann R, Falconnier C, Wolbers M, Widmer I, Neidert S, Fricker T, Blum C, Schild U. et al.Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA. 2009;302(10):1059–1066. doi: 10.1001/jama.2009.1297.
    1. Schuetz P, Albrich W, Christ-Crain M, Chastre J, Mueller B. Procalcitonin for guidance of antibiotic therapy. Expert Rev Anti Infect Ther. 2010;8(5):575–587. doi: 10.1586/eri.10.25.
    1. Schuetz P, Briel M, Mueller B. Clinical outcomes associated with procalcitonin algorithms to guide antibiotic therapy in respiratory tract infections. JAMA. 2013;309(7):717–718. doi: 10.1001/jama.2013.697.
    1. Schuetz P, Muller B, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolff M, Chastre J, Tubach F. et al.Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev. 2012;9:CD007498.
    1. Cals JW, Schot MJ, de-Jong SA, Dinant GJ, Hopstaken RM. Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Ann Fam Med. 2010;8(2):124–133. doi: 10.1370/afm.1090.
    1. Pierrakos C, Vincent JL. Sepsis biomarkers: a review. Crit Care. 2010;14(1):R15. doi: 10.1186/cc8872.
    1. Schuetz P, Affolter B, Hunziker S, Winterhalder C, Fischer M, Balestra GM, Hunziker P, Marsch S. Serum procalcitonin, C-reactive protein and white blood cell levels following hypothermia after cardiac arrest: a retrospective cohort study. Eur J Clin Invest. 2010;40(4):376–381. doi: 10.1111/j.1365-2362.2010.02259.x.
    1. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M. Early Goal-Directed Therapy Collaborative G: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19):1368–1377. doi: 10.1056/NEJMoa010307.
    1. Shapiro NI, Trzeciak S, Hollander JE, Birkhahn R, Otero R, Osborn TM, Moretti E, Nguyen HB, Gunnerson KJ, Milzman D. et al.A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis. Crit Care Med. 2009;37(1):96–104. doi: 10.1097/CCM.0b013e318192fd9d.
    1. Shapiro NI, Howell MD, Talmor D, Nathanson LA, Lisbon A, Wolfe RE, Weiss JW. Serum lactate as a predictor of mortality in emergency department patients with infection. Ann Emerg Med. 2005;45(5):524–528. doi: 10.1016/j.annemergmed.2004.12.006.
    1. Shapiro NI, Yano K, Okada H, Fischer C, Howell M, Spokes KC, Ngo L, Angus DC, Aird WC. A prospective, observational study of soluble FLT-1 and vascular endothelial growth factor in sepsis. Shock. 2008;29(4):452–457. doi: 10.1097/SHK.0b013e31815072c1.
    1. Shapiro NI, Yano K, Sorasaki M, Fischer C, Shih SC, Aird WC. Skin biopsies demonstrate site-specific endothelial activation in mouse models of sepsis. J Vasc Res. 2009;46(5):495–502. doi: 10.1159/000210662.
    1. Schuetz P, Castro P, Shapiro NI. Diabetes and sepsis: preclinical findings and clinical relevance. Diabetes Care. 2011;34(3):771–778. doi: 10.2337/dc10-1185.
    1. Schuetz P, Yano K, Sorasaki M, Ngo L, St Hilaire M, Lucas JM, Aird W, Shapiro NI. Influence of diabetes on endothelial cell response during sepsis. Diabetologia. 2011.
    1. Schuetz P, Aird W, Jones AE, Shapiro NI. Diabetes is not associated with Increased Mortality in Emergency Department Patients with Sepsis. Ann Emerg Med. 2011. in press.
    1. Schuetz P, Jones AE, Aird W, Shapiro NI. Endothelial Cell Activation in Emergency Department Patients with Sepsis and Non-sepsis related Hypotension. Shock (Augusta, Ga. 2011. in press.
    1. Muller B, Morgenthaler N, Stolz D, Schuetz P, Muller C, Bingisser R, Bergmann A, Tamm M, Christ-Crain M. Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections. Eur J Clin Invest. 2007;37(2):145–152. doi: 10.1111/j.1365-2362.2007.01762.x.
    1. Christ-Crain M, Stolz D, Jutla S, Couppis O, Muller C, Bingisser R, Schuetz P, Tamm M, Edwards R, Muller B. et al.Free and total cortisol levels as predictors of severity and outcome in community-acquired pneumonia. Am J Respir Crit Care Med. 2007;176(9):913–920. doi: 10.1164/rccm.200702-307OC.
    1. Vazquez M, Jockers K, Christ-Crain M, Zimmerli W, Muller B, Schuetz P. MR-pro-atrial natriuretic peptide (MR-proANP) predicts short- and long-term outcomes in respiratory tract infections: A prospective validation study. Int J Cardiol. 2010;156(1):16–23.
    1. Muller B, Suess E, Schuetz P, Muller C, Bingisser R, Bergmann A, Stolz D, Tamm M, Morgenthaler NG, Christ-Crain M. Circulating levels of pro-atrial natriuretic peptide in lower respiratory tract infections. J Intern Med. 2006;260(6):568–576. doi: 10.1111/j.1365-2796.2006.01722.x.
    1. Lim WS, van der-Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, Lewis SA, Macfarlane JT. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58(5):377–382. doi: 10.1136/thorax.58.5.377.
    1. Patel KV, Semba RD, Ferrucci L, Newman AB, Fried LP, Wallace RB, Bandinelli S, Phillips CS, Yu B, Connelly S. et al.Red cell distribution width and mortality in older adults: a meta-analysis. The journals of gerontology Series A, Biological sciences and medical sciences. 2010;65(3):258–265.
    1. Felker GM, Allen LA, Pocock SJ, Shaw LK, McMurray JJ, Pfeffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL. et al.Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol. 2007;50(1):40–47. doi: 10.1016/j.jacc.2007.02.067.
    1. Braun E, Domany E, Kenig Y, Mazor Y, Makhoul BF, Azzam ZS. Elevated red cell distribution width predicts poor outcome in young patients with community acquired pneumonia. Crit Care. 2011;15(4):R194. doi: 10.1186/cc10355.
    1. Shibata H. Nutritional factors on longevity and quality of life in Japan. J Nutr Health Aging. 2001;5(2):97–102.
    1. Goebel S, Mehdorn HM. Measurement of psychological distress in patients with intracranial tumours: the NCCN distress thermometer. J Neurooncol. 2011;104(1):357–364. doi: 10.1007/s11060-010-0501-5.
    1. Lee SJ, Katona LJ, De-Bono SE, Lewis KL. Routine screening for psychological distress on an Australian inpatient haematology and oncology ward: impact on use of psychosocial services. The Medical journal of Australia. 2010;193(5 Suppl):S74–S78.
    1. Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988;54(6):1063–1070.
    1. Lowe B, Wahl I, Rose M, Spitzer C, Glaesmer H, Wingenfeld K, Schneider A, Brahler E. A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. J Affect Disord. 2010;122(1–2):86–95.
    1. Cook NR. Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve. Clin Chem. 2008;54(1):17–23.
    1. Pencina MJ, D‘Agostino RB Sr, D‘Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27(2):157–172. doi: 10.1002/sim.2929. discussion 207–112.
    1. Schuetz P, Albrich WC, Suter I, Hug BL, Christ-Crain M, Holler T, Henzen C, Krause M, Schoenenberger R, Zimmerli W. et al.Quality of care delivered by fee-for-service and DRG hospitals in Switzerland in patients with community-acquired pneumonia. Swiss Med Wkly. 2011;141:w13228.

Source: PubMed

3
Subskrybuj